Zurcher Kantonalbank Zurich Cantonalbank trimmed its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 21.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 44,224 shares of the company's stock after selling 11,888 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Clorox were worth $4,459,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Center for Financial Planning Inc. acquired a new position in Clorox during the third quarter worth $25,000. Vermillion & White Wealth Management Group LLC acquired a new position in Clorox during the third quarter worth $25,000. True Wealth Design LLC increased its position in Clorox by 1,020.0% during the third quarter. True Wealth Design LLC now owns 224 shares of the company's stock worth $28,000 after buying an additional 204 shares during the last quarter. Root Financial Partners LLC acquired a new position in Clorox during the third quarter worth $29,000. Finally, Darwin Wealth Management LLC acquired a new position in Clorox during the second quarter worth $29,000. 78.53% of the stock is owned by institutional investors and hedge funds.
Clorox Stock Up 1.0%
NYSE CLX opened at $98.68 on Friday. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.48 and a current ratio of 0.74. The firm has a 50-day simple moving average of $110.40 and a 200 day simple moving average of $109.48. The Clorox Company has a twelve month low of $96.58 and a twelve month high of $143.96. The stock has a market cap of $11.93 billion, a PE ratio of 16.12, a PEG ratio of 0.48 and a beta of 0.65.
Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the previous year, the business posted $1.55 EPS. The firm's quarterly revenue was down .8% on a year-over-year basis. On average, research analysts forecast that The Clorox Company will post 5.87 EPS for the current year.
Clorox Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Wednesday, April 22nd will be paid a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 5.0%. The ex-dividend date is Wednesday, April 22nd. Clorox's dividend payout ratio (DPR) is presently 81.05%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on CLX shares. Wall Street Zen raised Clorox from a "sell" rating to a "hold" rating in a research report on Saturday, February 7th. Deutsche Bank Aktiengesellschaft lowered their price target on Clorox from $101.00 to $100.00 and set a "hold" rating on the stock in a research report on Monday, April 20th. Jefferies Financial Group lowered their price target on Clorox from $151.00 to $139.00 and set a "buy" rating on the stock in a research report on Tuesday. Rothschild & Co Redburn set a $117.00 price target on Clorox in a research report on Friday, February 13th. Finally, BNP Paribas Exane raised Clorox from an "underperform" rating to a "neutral" rating in a research report on Wednesday, February 11th. One investment analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Reduce" and an average target price of $111.33.
View Our Latest Stock Analysis on CLX
Clorox Profile
(
Free Report)
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.